Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Essential Pharma

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$8M
Portfolio companies 4
Rounds per year 0.27
Lead investments 0
Key employees Soon

Areas of investment

  • Biotechnology
  • Biometrics
  • Genetics
  • Life Science
  • Manufacturing

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aletra Capital Partners -
Allegheny Financial Group Pennsylvania, Pittsburgh, United States
Armada Capital Distrito Federal, Mexico, Mexico City
Atos International Chiba Prefecture, Japan, Tateyama
Bennett Capital Co. New York, New York, United States
CAC California, San Diego, United States
Canyon Partners California, Los Angeles, United States
China Fortune-Tech Capital China, Shanghai
Diligent Capital Partners Kyiv, Ukraine, Київська міська громада
Emerson Ventures Canada, Ontario, Toronto
Etoile Media group France, Ile-de-France, Paris
Handok -
JF2 Capital Partners Dallas, Texas, United States
Jilin University Alumni Fund -
Lennox Capital Partners Dallas, Texas, United States
RMB Funds Chicago, Illinois, United States
Techstars Chicago (Formerly Excelerate Labs) Chicago, Illinois, United States
Weizhong Xiang Jijin China, Jiangsu, Nanjing
WisdoMont Asset Management China, Huangpu, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Modulus Discovery

Biotechnology
Clinical Trials
Pharmaceutical
$25M13 May 2020 Chiyoda, Japan

HekaBio

Health Care
$5M07 Dec 2018 Chiyoda, Japan

HACARUS

Artificial Intelligence
Life Science
Machine Learning
Manufacturing
Medical
Software
$2M05 Oct 2018 Kyoto, Kyoto Prefecture, Japan

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Essential Pharma?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 4
Average round size 8M
Rounds per year 0.27
Peak activity year 2018
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Modulus Discovery

Biotechnology
Clinical Trials
Pharmaceutical
$25M13 May 2020 Chiyoda, Japan

HekaBio

Health Care
$5M07 Dec 2018 Chiyoda, Japan

HACARUS

Artificial Intelligence
Life Science
Machine Learning
Manufacturing
Medical
Software
$2M05 Oct 2018 Kyoto, Kyoto Prefecture, Japan
Crunchbase icon

Content report

The following text will be sent to our editors: